* Crown Electrokinetics Corp. CRKN.OQ CRKN.O is expected
to report results on November 12.
* Refinitiv's mean analyst estimate for Crown Electrokinetics
Corp. is for a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Crown
Electrokinetics Corp. is $11, about 63.2% above its last
closing price of $4.05.
This summary was machine generated November 10 at 13:40 GMT.
All figures in US dollars unless otherwise stated